iNtRON Biotechnology, Inc. (KOSDAQ:048530)

iNtRON Biotechnology Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 28, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	123,232	183,560	291,422	269,879	709,999	915,063
Market Cap Growth	-32.87%	-37.01%	7.98%	-61.99%	-22.41%	97.15%
Enterprise Value	88,305	129,604	224,880	175,332	642,575	858,619
Last Close Price	4020.00	5443.04	8374.55	7664.08	19843.65	26253.96
PE Ratio	-	-	-	47.25	72.99	61.22
PS Ratio	22.17	28.60	30.40	19.27	24.23	20.14
PB Ratio	1.67	2.19	3.01	2.54	7.01	10.72
P/TBV Ratio	1.69	2.23	3.06	2.58	7.09	10.88
P/FCF Ratio	-	-	-	72.00	52.88	401.50
P/OCF Ratio	-	-	93.48	45.15	43.10	128.32
EV/Sales Ratio	15.89	20.19	23.46	12.52	21.93	18.90
EV/EBITDA Ratio	-	-	-	1999.30	55.33	49.62
EV/EBIT Ratio	-	-	-	-	63.76	54.56
EV/FCF Ratio	-14.82	-	-	46.78	47.86	376.74
Debt / Equity Ratio	0.04	0.02	0.00	0.30	0.45	0.12
Debt / EBITDA Ratio	-	-	-	356.59	3.94	0.59
Debt / FCF Ratio	-	-	-	8.34	3.41	4.51
Asset Turnover	0.07	0.07	0.08	0.10	0.23	0.48
Inventory Turnover	2.46	2.57	4.20	4.89	6.01	13.19
Quick Ratio	8.68	37.96	76.13	3.50	3.73	6.16
Current Ratio	10.70	39.03	77.59	3.54	3.77	6.40
Return on Equity (ROE)	-7.70%	-2.87%	-9.56%	5.50%	10.42%	19.88%
Return on Assets (ROA)	-5.31%	-3.54%	-1.71%	-0.63%	4.96%	10.38%
Return on Invested Capital (ROIC)	-19.39%	-13.93%	-9.51%	-3.24%	29.38%	68.95%
Return on Capital Employed (ROCE)	-9.70%	-6.20%	-3.40%	-1.40%	8.40%	17.90%
Earnings Yield	-5.10%	-1.41%	-3.33%	2.12%	1.37%	1.63%
FCF Yield	-4.84%	-0.69%	-1.60%	1.39%	1.89%	0.25%
Dividend Yield	2.62%	1.84%	-	-	-	-
Buyback Yield / Dilution	3.69%	0.87%	2.16%	-0.58%	4.41%	-6.08%
Total Shareholder Return	6.38%	2.70%	2.16%	-0.58%	4.41%	-6.08%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.